COMMUNIQUÉS West-GlobeNewswire

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality
07/05/2026
Preliminary research suggests that D-cycloserine significantly enhances the effect of Transcranial Magnetic Stimulation (TMS) Trial is planned to be conducted at a leading US academic teaching hospital, three HOPE [...]
Biotech’s Next Wave May Already be in Motion
07/05/2026
Insider Bets on what may become a Brain Cancer Moonshot DENVER, May 07, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com and NeOnc Technology) - The biotech and pharma sector is entering one of its most pivotal periods [...]
MediWound to Report First Quarter 2026 Financial Results
07/05/2026
MediWound to Report First Quarter 2026 Financial Results Conference Call and Webcast Scheduled for Wednesday, May 27 th at 8:30 a.m. Eastern Time YAVNE, Israel, May 7, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global [...]
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
07/05/2026
US Under Secretary of Commerce Jeffrey Kessler, Texas State Senator Brent Hagenbuch, Novartis leadership mark expansion of company’s coast - to - coast RLT manufacturing network – the largest in the US Expanded [...]
Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings
07/05/2026
WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant [...]
Krystal Biotech to Present at BofA Securities 2026 Health Care Conference
07/05/2026
PITTSBURGH, May 07, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the BofA Securities 2026 Health Care Conference on May 13, 2026, in [...]
Stryker declares an $0.88 per share quarterly dividend
07/05/2026
Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the [...]
Tria Federal Unveils Integrated Solutions Platform and New Website
07/05/2026
Tria helps federal health agencies achieve their critical missions by navigating complex tradeoffs between cost, quality, and access to care ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Tria Federal has unveiled a [...]
MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights
07/05/2026
Results from Phase 2 trial of once-weekly canvuparatide accepted for oral presentation at ENDO in June 2026 Phase 3 trial of once-weekly canvuparatide on track to initiate in Q3 2026 Appointment of Mark Soued as Chief [...]
UroGen Pharma to Present at Upcoming Investor Conferences
07/05/2026
PRINCETON, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today [...]
Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline
07/05/2026
Proceeds support commercialization of Arbli ™ , the first FDA-approved ready-to-use oral suspension for hypertension; and REZENOPY ™ , life-saving opioid overdose emergency treatment Financing also drives early- and [...]
Aardvark Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
07/05/2026
ARD-101 and ARD-201 programs on voluntary pause; further guidance expected in Q2 2026 $91.2 million in cash, cash equivalents and short-term investments as of March 31, 2026, supports projected operations into mid-2027 [...]
ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results
07/05/2026
SAN DIEGO, May 07, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic [...]
Willis Knighton Health Selects Commure as Enterprise Ambient Scribe AI Partner
07/05/2026
MOUNTAIN VIEW, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Commure , a leading healthcare technology company, today announced it has been selected by Willis Knighton Health as its enterprise Ambient AI partner. Following a [...]
SERB Pharmaceuticals Announces ThyroSafe 130 mg Potassium Iodide Tablets are Now Commercially Available in the US
07/05/2026
WEST CONSHOHOCKEN, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company focused on rare diseases and medical emergencies, announced that ThyroSafe potassium iodide [...]
Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026
07/05/2026
20+ presentations highlight expanding role in pediatric lung disease, treatment-response assessment, and pharma trial endpoints DURHAM, NC and LONDON, May 07, 2026 (GLOBE NEWSWIRE) -- Polarean, a commercial-stage [...]
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
07/05/2026
AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on developing therapies for Tuberous Sclerosis [...]
Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA
07/05/2026
Official FDA meeting minutes and Phase 2 data provide guidance on the pivotal Phase 3 registration path for CAD-1005 in heparin-induced thrombocytopenia (HIT) PONTE VEDRA, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- Cadrenal [...]
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
07/05/2026
New initiative from Silo Pharma designed to align with federal actions to accelerate mental health innovation using psychedelic medicines Silo Pharma targets unmet need in a drug market with no FDA-approved therapies [...]

Pages